| Literature DB >> 34408626 |
Yong-Hui Zhang1, Yu-Chen Wang1, Gong-Wei Hu2, Xiao-Qin Ding2, Xiao-Hua Shen2, Hui Yang2, Ji-Feng Rong2, Xue-Qiang Wang1,3.
Abstract
BACKGROUND: Somatosensory impairments and pain are common symptoms following stroke. However, the condition of perception and pain threshold for pressure stimuli and the factors that can influence this in individuals with stroke are still unclear. This study aimed to investigate the gender differences in pressure pain threshold (PPT) and positive somatosensory signs for pressure stimuli, and explore the effects of joint pain, motor function, and activities of daily living (ADL) on pain threshold in post-stroke patients.Entities:
Keywords: hemiplegia; hyperalgesia; hypoalgesia; pain threshold; somatosensory; stroke
Year: 2021 PMID: 34408626 PMCID: PMC8366776 DOI: 10.3389/fnins.2021.705516
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Demographics and characteristics of the participants.
| All participants ( | Male ( | Female ( |
| |
| Age (years) | 68.50 (56.25–73.00) | 68.00 (55.00–71.00) | 72.00 (60.00–78.00) | 0.064 |
| BMI (kg/m2) | 23.77 (22.15–26.30) | 23.88 (22.60–26.12) | 23.44 (19.01–26.70) | 0.466 |
| Smoking, n (%) | 26 (43.3%) | 25 (64.1%) | 1 (4.8%) | 0.000 |
| Drinking, n (%) | 20 (33.3%) | 19 (48.7%) | 1 (4.8%) | 0.001 |
| Right dominant hand, n (%) | 60 (100.0%) | 39 (100.0%) | 21 (100%) | NA |
| Right affected side, n (%) | 31 (51.7%) | 21 (53.8%) | 10 (47.6%) | 0.645 |
| Stroke types, n (%) | 0.182 | |||
|
| 21 (35.0%) | 16 (41.0%) | 5 (23.8%) | NA |
|
| 39 (65.0%) | 23 (59.0%) | 16 (76.2%) | NA |
| Stroke onset (days) | 350.00 (208.35–554.75) | 353.00 (197.00–555.00) | 347.00 (236.50–536.50) | 0.938 |
| FMA-MF | 40.50 (25.25–76.25) | 41.00 (27.00–81.00) | 40.00 (24.00–66.00) | 0.545 |
| FMA-JP | 40.00 (33.25–44.00) | 40.00 (34.00–44.00) | 41.00 (32.50–44.00) | 0.994 |
| Barthel Index | 65.00 (46.25–85.00) | 64.00 (45.00–85.00) | 70.00 (45.00–85.00) | 0.975 |
Absolute pressure pain thresholds in all patients (kgf).
| All ( | Male ( | Female ( |
| |
|
| ||||
| MD | 3.19 (2.53–4.61) | 4.07 (3.01–5.02) | 2.66 (2.26–3.10) | 0.000 |
| BB | 2.13 (1.60–3.15) | 2.78 (2.04–3.33) | 1.75 (1.45–2.33) | 0.002 |
| L2 | 5.92 (4.31–8.67) | 6.28 (4.93–9.11) | 5.58 (3.54–7.03) | 0.045 |
| L4 | 6.09 (4.11–8.91) | 6.39 (5.38–10.75) | 5.52 (3.69–7.07) | 0.031 |
| RF | 3.94 (2.74–5.08) | 4.42 (3.09–5.47) | 2.72 (2.07–3.96) | 0.001 |
| BF | 4.67 (3.74–7.50) | 5.82 (4.16–8.21) | 3.88 (2.91–4.87) | 0.003 |
| TA | 4.61 (3.36–6.53) | 5.29 (3.79–7.40) | 3.63 (2.68–5.30) | 0.008 |
| MG | 4.25 (3.33–5.88) | 4.71 (3.41–6.31) | 3.88 (2.54–5.01) | 0.033 |
|
| ||||
| MD | 3.12 (2.34–4.45) | 3.70 (2.76–5.25) | 2.44 (1.92–3.15) | 0.000 |
| BB | 2.00 (1.58–2.83) | 2.42 (1.71–3.21) | 1.69 (1.27–2.14) | 0.001 |
| L2 | 5.79 (3.77–8.70) | 6.17 (4.80–9.31) | 4.16 (3.17–6.24) | 0.007 |
| L4 | 5.77 (4.11–8.25) | 6.70 (5.12–10.12) | 4.93 (3.62–6.71) | 0.006 |
| RF | 3.52 (2.61–5.26) | 4.21 (3.39–5.89) | 2.71 (1.83–2.99) | 0.000 |
| BF | 5.53 (3.93–7.11) | 6.28 (4.39–8.16) | 3.93 (3.29–5.91) | 0.004 |
| TA | 4.75 (3.43–6.00) | 4.91 (4.36–6.77) | 3.86 (2.62–5.05) | 0.005 |
| MG | 4.02 (2.84–5.49) | 4.34 (3.28–5.99) | 3.21 (2.49–4.43) | 0.012 |
FIGURE 1Gender differences in PPT values in the muscles in the upper extremities and trunk (kgf). All muscles, MD (A), BB (B), and L2 (C), L4 (D) levels of ES, at both sides performed significantly higher pressure pain thresholds in men than women with stroke (p < 0.05). * Representing a statistically significant difference with p < 0.05; ** representing a statistically significant difference with p < 0.01.
FIGURE 2Gender differences in PPT values in the muscles in the lower extremities (kgf). All muscles, RF (A), BF (B), TA (C), and MG (D), at both sides performed significantly higher pressure pain thresholds in men than women with stroke (p < 0.05). * Representing a statistically significant difference with p < 0.05; ** representing a statistically significant difference with p < 0.01.
Somatosensory signs for pressure stimuli (n,%).
| Positive signs | Negative sign | ||||
| Hypoalgesia | Hyperalgesia | All | |||
|
| |||||
| MD | 3 (7.69%) | 6 (15.38%) | 9 (23.08%) | 30 (76.92%) | 0.263 |
| BB | 7 (17.95%) | 3 (7.69%) | 10 (25.64%) | 29 (74.36%) | 0.650 |
| L2 | 3 (7.69%) | 0 (0) | 3 (7.69%) | 36 (92.31%) | 1.000 |
| L4 | 3 (7.69%) | 1 (2.56%) | 4 (10.26%) | 35 (89.74%) | 1.000 |
| RF | 3 (7.69%) | 2 (5.13%) | 5 (12.82%) | 34 (87.18%) | 0.221 |
| BF | 3 (7.69%) | 1 (2.56%) | 4 (10.26%) | 35 (89.74%) | 0.690 |
| TA | 5 (12.82%) | 0 (0) | 5 (12.82%) | 34 (87.18%) | 1.000 |
| MG | 4 (10.26%) | 1 (2.56%) | 5 (12.82%) | 34 (87.18%) | 0.411 |
|
| |||||
| MD | 4 (19.05%) | 1 (4.76%) | 5 (23.81%) | 16 (76.19%) | NA |
| BB | 6 (28.57%) | 1 (4.76%) | 7 (33.33%) | 14 (66.67%) | NA |
| L2 | 2 (9.52%) | 0 (0) | 2 (9.52%) | 19 (90.48%) | NA |
| L4 | 1 (4.76%) | 1 (4.76%) | 2 (9.52%) | 19 (90.48%) | NA |
| RF | 5 (23.81%) | 0 (0) | 5 (23.81%) | 16 (76.19%) | NA |
| BF | 2 (9.52%) | 4 (19.05%) | 6 (28.57%) | 15 (71.43%) | NA |
| TA | 2 (9.52%) | 0 (0) | 2 (9.52%) | 19 (90.48%) | NA |
| MG | 3 (14.29%) | 2 (9.52%) | 5 (23.81%) | 16 (76.19%) | NA |
|
| |||||
| MD | 7 (11.67%) | 7 (11.67%) | 14 (23.33%) | 46 (76.67%) | NA |
| BB | 13 (21.67%) | 4 (6.67%) | 17 (28.33%) | 43 (71.67%) | NA |
| L2 | 5 (8.33%) | 0 (0) | 5 (8.33%) | 55 (91.67%) | NA |
| L4 | 4 (6.67%) | 2 (3.33%) | 6 (10.00%) | 54 (90.00%) | NA |
| RF | 8 (13.33%) | 2 (3.33%) | 10 (16.67%) | 50 (83.33%) | NA |
| BF | 5 (8.33%) | 5 (8.33%) | 10 (16.67%) | 50 (83.33%) | NA |
| TA | 7 (11.67%) | 0 (0) | 7 (11.67%) | 53 (88.33%) | NA |
| MG | 7 (11.67%) | 3 (5.00%) | 10 (16.67%) | 50 (83.33%) | NA |
All significant between-group differences based on the medians of the assessment scales (kgf or%).
| Overall group ( | Male group ( | Female group ( | |||||||
|
|
| ||||||||
| Below-median | Above-median | p1 | Below-median | Above-median | p2 | Below-median | Above-median | p3 | |
|
|
|
|
|
|
|
| |||
| L2 (diff) | 0.77 (0.42–1.41) | 0.51 (0.27–0.90) | 0.015* | 0.74 (0.49–1.19) | 0.67 (0.31–1.17) | NS | 0.80 (0.33–1.87) | 0.28 (0.15–0.61) | 0.020* |
| L4 (diff) | 0.82 (0.57–1.27) | 0.49 (0.22–0.71) | 0.006** | 0.84 (0.62–1.29) | 0.43 (0.15–0.70) | 0.013* | 0.65 (0.49–1.28) | 0.54 (0.34–0.79) | NS |
|
|
|
|
|
|
|
| |||
| L2 (UA) | 5.35 (3.58–6.59) | 6.16 (4.39–9.87) | NS | 5.68 (4.18–8.51) | 8.07 (5.28–10.77) | 0.033* | 4.11 (3.22–6.59) | 4.32 (3.08–5.92) | NS |
| L4 (diff) | 0.74 (0.33–1.35) | 0.55 (0.23–0.79) | NS | 0.70 (0.26–1.69) | 0.64 (0.26–0.92) | NS | 0.93 (0.56–1.28) | 0.51 (0.14–0.65) | 0.024* |
| L4 (%) | 112 (100–122) | 102 (92–108) | 0.030* | 109 (100–127) | 100 (89–106) | 0.016* | 116 (90–122) | 110 (100–118) | NS |
| MG (diff) | 0.83 (0.43–1.18) | 0.50 (0.22–0.91) | 0.024* | 0.72 (0.37–1.15) | 0.61 (0.24–0.97) | NS | 1.07 (0.67–1.21) | 0.33 (0.11–0.89) | 0.002** |
| MG (%) | 122 (97–132) | 99 (92–117) | 0.027* | 113 (99–127) | 109 (94–122) | NS | 129 (92–154) | 93 (88–102) | 0.020* |
|
|
|
|
|
|
|
| |||
| MG (A) | 4.71 (3.52–6.08) | 3.97 (2.76–5.57) | NS | 4.51 (3.39–6.08) | 5.20 (3.51–7.39) | NS | 4.19 (3.69–5.60) | 2.63 (2.20–4.46) | 0.043* |
| MG (diff) | 0.98 (0.58–1.19) | 0.45 (0.22–0.89) | 0.008** | 0.72 (0.37–1.47) | 0.51 (0.24–0.92) | NS | 1.02 (0.54–1.18) | 0.55 (0.11–0.92) | 0.043* |
| MG (%) | 124 (105–131) | 96 (91–116) | 0.002** | 119 (105–129) | 100 (93–118) | 0.044* | 126 (92–138) | 96 (88–116) | NS |